Survey Shows FDA-Approved Breast Cancer AI Diagnostic Tool Is Less Effective Than Expected by Radiologists
Clinical Imaging survey: UC San Diego researchers polled 215 Society of Breast Imaging members and found breast cancer detection AI underperformed radiologists' expectations. About half used FDA-approved AI tools, 11% planned adoption, but most used them only as a second opinion, rarely decisive.....